Jul 10, 2019
On Episode 76 of the podcast, I spoke with Kristen Kneff from ImmunsanT about the presentation she gave at The State of Celiac event held in May by the Canadian Celiac Association. Kristen’s presentation, and our subsequent interview looked at the Phase 2 trial for Nexvax2, a vaccine to minimize the effects of gluten on those with celiac disease. Recently, the trial was halted, as the vaccine was not performing as expected.
Ellen Bayens of theceliacscene.com brought this to my attention in an article looking at both the press release from ImmunsanT and a position piece from Dr. Peter Green. On this episode of the podcast, Ellen and I speak about what this news means for the research community as well as the impact on the celiac community.
You can read the article at the following link –
Sue’s Websites and Social Media –
Podcast Blog – https://www.acanadianceliacblog.com
Facebook - @acanadianceliacpodcast
Twitter – CeliacPodcastCA
Email – email@example.com
Baking Website – https://www.suesglutenfreebaking.com
Instagram - @suesgfbaking
(search Sues Gluten Free Baking)
Email – firstname.lastname@example.org
Other Podcast – Gluten Free Weigh In – https://glutenfreeweighin.libsyn.com